As the song goes, "You can't always get what you want."
This applies well to the recent announcement of plans for full legalization of adult marijuana use in Canada. During that April 13 event, the Trudeau government said all will be in place by July 1, 2018.
But there was a "problem" – at least according to some legalization advocates and analysts.
Instead of laying everything out precisely, legalization in Canada is still evolving. For instance, individual Canadian provinces will have a lot of say about where and when marijuana can be sold, how old buyers can be, and taxation.
So there is much more work to do than was hinted by the government when it leaked preliminary legalization details back on March 27.
And out come the hand-wringers – fretting that legalization will be delayed or… maybe… never even happen.
Don't join these worrywarts.
Nothing here shatters the lucrative reality that double-, triple, or even quadruple-digit gains are on the way for the five stocks I included my latest report – How to Make a Fast Fortune on Canada's Upcoming Total Legalization of Marijuana.
In fact, there are four reasons why you don't need to lose sleep.
According to the plans unveiled on April 23, Canadian adults will be able to buy and possess up 30 grams of marijuana and pursue limited home growing by next summer. And that will make Canada the first large, industrialized nation to fully legalize and regulate weed.
Not even the Netherlands can make that claim.
But like I said, there is some criticism out there from legal cannabis advocates.
Folks seemed to be expecting near-finalized details during last Thursday's announcement – but legalization in Canada is still evolving.
You see, the individual Canadian provinces will have a lot of say about where and when marijuana can be sold, how old buyers can be (the new law says 18, but provinces can alter the age restriction), and the taxation rate.
Again, this is all normal in a large, bureaucratic nation like Canada. These things take time.
But before you plan to spend the next year up all night, take a look at these four reasons you can sleep peacefully…
Reason No. 1: Prime Minister Justin Trudeau Won Over Adult Voters with Weed
Just Trudeau won Canada's 2015 federal election on the strength of a couple of issues. Perhaps none was more prominent on the campaign trail than promises of full legalization.
The platform gave Trudeau a chance to win over medical users and loved ones who see them suffering less because of cannabis-based medicines. It also won points with parents and law enforcement because he continually emphasized that regulating marijuana would keep it out of the hands of kids and away from criminal enterprise.
There's also the "wink," as I'm calling it…
Trudeau is a smart, slick-talking politician. He doesn't have to say it out loud, but he knows that fiscal …
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.